Journal of Peking University(Health Sciences) >
Association between CMTM5 gene and coronary artery disease and the relative mechanism
Received date: 2018-12-13
Online published: 2020-12-13
Supported by
Foundation of Research and Development Plan of China Railway Corporation(J2017Z608);Youth Foundation(2017-q27);Open Research Funding of Central Laboratory of Beijing Shijitan Hospital Affiliated to the Capital Medical University(2019-KF28)
Objective: To elucidate the correlation between CKLF-like MARVEL transmembrane domain containing member 5 (CMTM5) gene and the risk of coronary artery disease (CAD), and to detect the effects of CMTM5 gene expression changes on the ability of adhesion and migration of THP-1 cells. Methods: Using case-control method, a total of 700 hospitalized patients in Shijitan Hospital were enrolled in this study. CAD were diagnosed by coronary angiography, which was defined as at least one blood vessel diameter stenosis ≥50% according to the result of coronary angiography. Reverse transcription-polymerase chain reaction (RT-PCR) method was used to detect CMTM5 gene expression; enzyme linked immunosorbent assay (ELISA) method to detect the plasma level of CMTM5; and Logistic regression to analyze CMTM5 genes and the risk of CAD. Human vascular endothelial cells (ECs) and THP-1 cells were cultivated, adhesion and Transwells experiments were used to evaluate the chemotactic capabi-lity of CMTM5 gene on THP-1 cells. Results: In this study, 350 CAD patients matched with 350 control patients were included. RT-PCR results revealed CMTM5 mRNA expression in CAD group was 3.45 times compared with control group, which was significantly higher than that in control group (P<0.05). The levels of CMTM5 plasma protein in CAD group was (206.1±26.9) μg/L, which was significantly higher than that in control group (125.3±15.2) μg/L (P<0.05). After adjusted for the risk factors of age, gender, BMI, smoking, hypertension, diabetes and hyperlipidemia, Logistic regression analysis results indicated that CMTM5 was the susceptibility factors of CAD, which still had significant correlation with CAD (P<0.05). Adhesion and Transwells experiments results revealed that the numbers of adhesion and migration of THP-1 cells in CMTM5 overexpression ECs group (EO group) were significantly higher than that in lenti-mock infected ECs group (EO-MOCK group), non-infected ECs group (EN group), lenti-mock infected ECs group (ES-MOCK group), and CMTM5 suppression ECs group (ES group). On the contrary, the numbers of adhesion and migration of THP-1 cells in ES group were significantly lower than that in the other four groups (P<0.01). Conclusion: CMTM5 gene was closely related to the development of CAD. CMTM5 overexpression promoted the adhesion and migration of THP-1, which might play a part in the mechanisms of atherosclerosis and CAD.
Key words: Atherosclerosis; Coronary artery disease; CMTM5; Gene
Teng-fei LIU , Tao LIN , Li-hui REN , Guang-ping LI , Jian-jun PENG . Association between CMTM5 gene and coronary artery disease and the relative mechanism[J]. Journal of Peking University(Health Sciences), 2020 , 52(6) : 1082 -1087 . DOI: 10.19723/j.issn.1671-167X.2020.06.015
| [1] | Hansson GK. Inflammation, atherosclerosis, and coronary artery disease[J]. N Engl J Med, 2005,352(16):1685-1695. |
| [2] | Weber C, Noels H. Atherosclerosis: current pathogenesis and therapeutic options[J]. Nat Med, 2011,17(11):1410-1422. |
| [3] | Aikawa M, Libby P. The vulnerable atherosclerotic plaque: pathogenesis and therapeutic approach[J]. Cardiovasc Pathol, 2004,13(3):125-138. |
| [4] | Koenen RR, Weber C. Chemokines: established and novel targets in atherosclerosis[J]. EMBO Mol Med, 2011,3(12):713-725. |
| [5] | Braunersreuther V, Mach F, Steffens S. The specific role of chemokines in atherosclerosis[J]. Thromb Haemost, 2007,97(5):714-721. |
| [6] | Zernecke A, Shagdarsuren E, Weber C. Chemokines in atherosclerosis: an update[J]. Arterioscler Thromb Vasc Biol, 2008,28(11):1897-1908. |
| [7] | Aukrust P, Halvorsen B, Yndestad A, et al. Chemokines and cardiovascular risk[J]. Arterioscler Thromb Vasc Biol, 2008,28(11):1909-1919. |
| [8] | Li H, Guo X, Shao L, et al. CMTM5-v1, a four-transmembrane protein, presents a secreted form released via a vesicle-mediated secretory pathway[J]. BMB Rep, 2010,43(3):182-187. |
| [9] | Voora D, Cyr D, Lucas J, et al. Aspirin exposure reveals novel genes associated with platelet function and cardiovascular events[J]. J Am Coll Cardiol, 2013,62(14):1267-1276. |
| [10] | 刘滕飞, 张婧薇, 陈夏欢, 等. CMTM5基因rs723840单核苷酸多态性与阿司匹林治疗下血小板高反应性的相关性研究[J]. 北京大学学报(医学版), 2015,47(6):905-909. |
| [11] | Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation[J]. N Engl J Med, 2006,354(6):610-621. |
| [12] | Heydtmann M, Adams DH. Chemokines in the immunopathogenesis of hepatitis C infection[J]. Hepatology, 2009,49(2):676-688. |
| [13] | Golay J, Introna M. Chemokines and antagonists in non-Hodgkin’s lymphoma[J]. Expert Opin Ther Targets, 2008,12(5):621-635. |
| [14] | Tiemessen CT, Kuhn L. CC chemokines and protective immunity: insights gained from mother-to-child transmission of HIV[J]. Nat Immunol, 2007,8(3):219-222. |
| [15] | Dhami H, Fritz CE, Gankin B, et al. The chemokine system and CCR5 antagonists: potential in HIV treatment and other novel therapies[J]. J Clin Pharm Ther, 2009,34(2):147-160. |
| [16] | Lundberg GA, Kellin A, Samnegard A, et al. Severity of coronary artery stenosis is associated with a polymorphism in the CXCL16/SR-PSOX gene[J]. J Intern Med, 2005,257(5):415-422. |
| [17] | Singh N, Rai H, Sinha N, et al. Association of V249I and T280M polymorphisms in the chemokine receptor CX3CR1 gene with early onset of coronary artery disease among North Indians[J]. Genet Test Mol Biomarkers, 2012,16(7):756-760. |
| [18] | Cai W, Tao J, Zhang X, et al. Contribution of homeostatic chemokines CCL19 and CCL21 and their receptor CCR7 to coronary artery disease[J]. Arterioscler Thromb Vasc Biol, 2014,34(9):1933-1941. |
| [19] | Zhang JW, Liu TF, Chen XH, et al. Validation of aspirin response-related transcripts in patients with coronary artery disease and preliminary investigation on CMTM5 function[J]. Gene, 2017,624:56-65. |
/
| 〈 |
|
〉 |